NKTR - NEKTAR THERAPEUTICS
IEX Last Trade
0.9442
0.024 2.489%
Share volume: 31,646
Last Updated: Thu 26 Dec 2024 08:30:05 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
1.30%
PREVIOUS CLOSE
CHG
CHG%
$0.92
0.02
2.55%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | |
| Report Date | 2022-05-06 | 2022-08-05 | 2022-11-04 | 2023-02-28 | 2023-05-10 | 2023-08-09 | 2023-11-08 | 2024-03-05 | |
| Total revenue | 24.822 M | 21.585 M | 23.625 M | 22.023 M | 21.594 M | 20.499 M | 24.144 M | 23.885 M | |
| Cost of revenue | 5.315 M | 5.115 M | 4.972 M | 6.233 M | 7.060 M | 6.994 M | 12.431 M | 7.283 M | |
| Gross profit | 19.507 M | 16.470 M | 18.653 M | 15.790 M | 14.534 M | 13.505 M | 11.713 M | 16.602 M | |
| -15.57% | 13.25% | -15.35% | -7.95% | -7.08% | -13.27% | 41.74% | |||
| Operating expenses | 134.592 M | 63.261 M | 56.124 M | 56.679 M | 51.550 M | 47.550 M | 45.217 M | 47.262 M | |
| Selling general and admin | 27.339 M | 20.521 M | 22.534 M | 21.939 M | 21.081 M | 17.869 M | 21.147 M | 17.320 M | |
| Research and development | 107.253 M | 42.740 M | 33.590 M | 34.740 M | 30.469 M | 29.681 M | 24.070 M | 29.942 M | |
| Total expenses | 139.907 M | 68.376 M | 61.096 M | 62.912 M | 58.610 M | 54.544 M | 57.648 M | 54.545 M | |
| -51.13% | -10.65% | 2.97% | -6.84% | -6.94% | 5.69% | -5.38% | |||
| Operating income | -115.085 M | -46.791 M | -37.471 M | -40.889 M | -37.016 M | -34.045 M | -33.504 M | -30.660 M | |
| Ebit | -115.085 M | -46.791 M | -37.471 M | -40.889 M | -37.016 M | -34.045 M | -33.504 M | -30.660 M | |
| Pretax income | -90.267 M | -158.968 M | -59.204 M | -56.544 M | -137.081 M | -51.169 M | -45.898 M | -42.108 M | |
| 76.11% | -62.76% | -4.49% | 142.43% | -62.67% | -10.30% | -8.26% | |||
| Income tax | 126.000 K | 100.000 K | -155.000 K | 3.144 M | -63.000 K | -47.000 K | -61.000 K | -29.000 K | |
| Net income basic | -90.393 M | -159.068 M | -59.049 M | -59.688 M | -137.018 M | -51.122 M | -45.837 M | -42.079 M | |
| -75.97% | 62.88% | -1.08% | -129.56% | 62.69% | 10.34% | 8.20% | |||
| Net income | -90.393 M | -159.068 M | -59.049 M | -59.688 M | -137.018 M | -51.122 M | -45.837 M | -42.079 M | |
| -75.97% | 62.88% | -1.08% | -129.56% | 62.69% | 10.34% | 8.20% |